This article is more than 5 years old. Information may no longer be current.

Olympus aims to improve endoscopy through partnership with ai4gi

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, Healio Gastroenterology and Liver Disease spoke with Kurt Heine, endoscopy division group vice president of Olympus Corporation for the Americas, about the recently announced codevelopment agreement between ai4gi and Olympus for endoscopic development.

“Artificial intelligence is all around us right now and in everything we do on a daily basis, so an entrance into health care makes perfect sense,” Heine said. “We want to try to address the triple aim of trying to improve clinical outcomes, patient satisfaction and the cost of the procedure. We feel this [agreement] will help us attain those different things.”

To hear more about ai4gi, watch the video with company founder Michael Byrne, MD, and the video with ai4gi’s advisory board chairman Douglas K. Rex, MD.

Disclosure: Heine is an employee of Olympus Corporation of the Americas.